Expectant treatment with curative intent in the prostate-specific antigen era: triggers for definitive therapy.

@article{Warlick2006ExpectantTW,
  title={Expectant treatment with curative intent in the prostate-specific antigen era: triggers for definitive therapy.},
  author={Christopher A Warlick and Mohamad E. Allaf and Herbert Ballentine Carter},
  journal={Urologic oncology},
  year={2006},
  volume={24 1},
  pages={
          51-7
        }
}
Expectant treatment with curative intent for treatment of low-risk prostate cancer faces 3 challenges in the PSA era: (1) appropriate patient selection, (2) adequate surveillance strategies, and (3) identification of triggers for definitive intervention when cure is still possible. Men 65 years or older with T1c disease, prostate-specific antigen density <0.15 ng/ml/cm3, and favorable biopsy characteristics per the Epstein criteria currently appear to be the safest candidates for expectant… CONTINUE READING
BETA